An Open Letter to Members of the Maryland Chapter of the American College of Cardiology (MDACC) and Patients Regarding Stent Procedure Articles.

On Tuesday, July 5th, the Journal of the American Medical Association (JAMA) released a study, which examined the appropriateness of percutaneous coronary intervention (PCI) procedures. The study included a review of records from 1,091 U.S. hospitals who participate in the CathPCI Registry of the National Cardiovascular Registry Data Base (NCDR). Records captured between July 1, 2009 and Sept. 30, 2010 found that a vast majority of PCIs performed in acute (emergency) settings (98.6 percent) were classified as appropriate. For non-acute (non-emergency) indications, however, 11.6 percent were classified as inappropriate, with substantial variation noted across hospitals. These classifications were based on the American College of Cardiology's Appropriate Use Criteria (AUC) for Coronary Revascularization.

Overall, the study found that although the majority of patients are appropriately selected for stent procedures, there are opportunities for improvement, especially in the non-emergency setting. Studies like these are extremely beneficial to patients and to cardiovascular specialists and highlight the need for physicians and hospitals to continue to work together to implement policies that will improve patient safety and quality of care while reducing costs. Maryland is the only state in the nation that mandates hospital use of the CathPCI registry. MD-ACC believes additional policies are needed to further leverage data and clinical expertise to benefit patients. We commend Maryland physicians and institutions who have taken aggressive steps in recent months to address patient concerns regarding inappropriate stent procedures. We ask them to work with us and Maryland health care officials to establish a clear, consistent policy to achieve this goal.

Specifically, we support:

  • Transparent, external peer review of physicians and institutions who perform stent procedures
  • Accreditation of catheritization labs
  • The use of billing and clinical data to not only identify bad actors, but to improve patient safety and quality of care.

For more information on the study, click here.

Sincerely, Sam Goldberg, MD, FACC President